Cannabinoids

Articles

Currently in the life cycle of the cannabis industry, it is not obvious where the heavy metal regulatory landscape will end up. Clearly, the big four are not enough, but what is a realistic panel that reflects the real world of cannabinoid production?

Expanding the Panel of Heavy Metal Contaminants in Cannabis and Hemp Beyond the Big Four:  What Is the Regulatory Evidence Telling Us?

In the work presented here, the author shares research from collecting reports from the New Jersey State laboratory (the Department of Health’s Environmental and Chemical Laboratory Services), which has conducted testing for the state’s medicinal program. He documented an average variance of 20% in potency levels from different samples of the same test lot.

Degree of Variance in THC Levels in Samples Taken from Single Lots  of Medical Cannabis

Lo Friesen is the founder, CEO, and Chief Extractor of Heylo. With a background in chemistry and clinical research, Lo was inspired to explore cannabis as a medicine and to enter the emerging industry. She joined Eden Labs, a leading CO

 extraction equipment manufacturer to support and expand a Research and Development department. There she managed the development of their latest and greatest CO

 extraction system. In 2017, after working with Eden Labs and another cannabis processor, Lo launched Heylo with a mission to help people get more out of life with cannabis.

A review of the claims that differences in extract type can affect cost, ease of formulation, and the experience of the finished product.

Does Extract Type Make  a Difference in Cannabis Edibles?

In the work presented here, the authors pursue a more detailed understanding of the naturally rare occurring cannabinoid analogue, hexahydrocannabinol (HHC), by exploring the safety profile using a third-party lab to produce preclinical in vitro safety profile data. The purpose of these studies is to demonstrate HHC as a safe cannabinoid for potential human consumption.

Nonclinical In Vitro Safety Assessment Summary of Hemp Derived (R/S)-Hexahydrocannabinol ((R/S)-HHC)

This article examines why we should be studying the cannabinoids beyond THC and CBD in order to explore their potential medical value.

The Case for THCA and Other Minor Cannabinoids

Understanding the biochemical and physical process that comprise and control leaf-level physiology gives us deep insight into the plant, which may convert directly to cultivation practices.


Reading the Leaves: Adventures in the Leaf-Level  Physiology of Cannabis

The various extract types are defined so there can be some consensus once and for all.

Concentrate...What Do You Call It?

Part II of this series reviews the history of vape products, producing cannabis vapes, the myriad of extract types, and how temperature and hardware impact the user experience.


What’s in a Vape? Part II

On May 19, 2022 a federal appeals court ruled in a California vaping dispute that delta-8 tetrahydrocannabinol (THC) derived from hemp is “lawful.”

US Appeals Court Rules Hemp-Derived Delta-8 THC Products Legal 

The science of cannabis is in its beginning stages and has a large opportunity for growth advancement. Market Manager for Cannabis for Shimadzu, Eberhardt Kuhn, Ph.D., will be presenting two talks for both the hemp and analytical tracks, “Starting with the Roots - the Many Uses of Hemp” and “Delta Dawn - the Next Generation of Cannabinoids?” If you are interested in exploring hemp or cannabidiol (CBD) and other cannabinoids, check out both of these presentations to learn more! In this interview, Kuhn also discusses his interests in the cannabis industry and other presenters at the Cannabis Science Conference (CSC) West taking place in Long Beach, California from May 18–20, 2022.